Addex Therapeutics (ADXN) vs Enveric Biosciences (ENVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($6.1 million vs $6.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADXN | ENVB |
|---|---|---|
| Share price | $3.47 | $1.35 |
| Market cap | $6.08M | $6.04M |
| 1-day change | +2.06% | -4.26% |
| EPS (TTM) | $-7.56 | $-13.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-8.77M |
| 52-week high | $10.43 | $13.25 |
| 52-week low | $2.56 | $1.17 |
| Distance from 52-week high | -66.73% | -89.81% |
| Average volume | 383.35K | 56.55K |
| Shares outstanding | 1.75M | 4.48M |
| Employees | 3 | 5 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Enveric Biosciences
ENVB stock →Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
ADXN vs ENVB FAQ
Which is bigger, Addex Therapeutics or Enveric Biosciences?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $6.08M compared with $6.04M for Enveric Biosciences (ENVB).
Are Addex Therapeutics and Enveric Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.